General
Australian AstraZeneca manufacturer CSL still committed to make 50 million vaccine doses
The Australian manufacturer of the AstraZeneca COVID-19 vaccine says it still plans to fill a federal government order of 50 million doses, despite health authorities recommending a different vaccine be preferred for those under 50 years of age.
Key points:
- CSL says it remains “committed to meeting its contracted arrangements” with the Australian government and AstraZeneca
- An expert panel has advised that the Pfizer vaccine is preferred for people under 50
- The federal government expects CSL will soon start producing one million AstraZeneca doses per week
On Thursday night, the panel of experts that advises the federal government on immunisation issues recommended that Pfizer be the preferred COVID-19 vaccine for adults under 50 due to the…
-
Business22 hours agoThis artificial intelligence (AI) and “Magnificent Seven” stock will be the next company to surpass a $3 trillion market cap by the end of 2025
-
Noosa News22 hours agoYIMBYs vs NIMBYs as the battle for affordable housing moves into your backyard
-
General23 hours agoFootballers and movie stars: PM’s Shanghai tourism push
-
Business22 hours agoNvidia reaches the $4 trillion mark. Can it hit $5 trillion in 2025?